Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 1, 1996
[Natural or artificial surfactants? Arguments in favour of natural surfactants]H Walti
Pediatrie|January 1, 1990
[Effects of exogenous surfactants on mortality and main complications of hyaline membrane disease]H Walti, J P Relier
Drug Safety|May 20, 1998
A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndromeH Walti, M Monset-Couchard
Pediatric Research|January 1, 1997
Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytesH Walti, B S Polla, M Bachelet
The European Respiratory Journal. Supplement|March 1, 1989
Neonatal diagnosis of respiratory distress syndromeH Walti, M Couchard, J P Relier
Acta Paediatrica (Oslo, Norway : 1992)|August 1, 1995
Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. The French Collaborative Multicentre Study GroupH Walti, J Paris-Llado, G Bréart, et al.
Biology of the Neonate|January 1, 1992
Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birthH Walti, M Boulé, G Moriette, et al.
Biology of the Neonate|August 6, 1998
Heliox tolerance in spontaneously breathing neonates with bronchopulmonary dysplasiaE de Gamarra, G Moriette, M Farhat, et al.
Life Sciences|March 9, 1999
Modified natural porcine surfactant modulates tobacco smoke-induced stress response in human monocytesF Pinot, M Bachelet, D François, et al.
Pediatrics|July 1, 1997
Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant CurosurfJ Egberts, R Brand, H Walti, et al.
Pageof 3